US Congress House Bill 4056 (Prior Session Legislation)

---

Spectrum: Moderate Partisan Bill (Republican 6-1)
Status: Introduced on February 16 2012 - 25% progression, died in committee
Action: 2012-02-16 - Referred to the House Committee on Energy and Commerce.
Pending: House Energy And Commerce Committee
Text: Latest bill text (Introduced) [PDF]

Science and Technology Regulatory Relief Act of 2012 - Amends the Federal Food, Drug, and Cosmetic Act to prohibit a state or political subdivision from conducting or requiring an inspection of a factory, warehouse, or establishment in which a drug or device is manufactured, processed, packed, or held by a manufacturer or wholesale distributor for introduction into interstate commerce, or after such introduction, for purposes of verifying compliance with such Act, Public Health Service Act requirements regarding the regulation of biological products, or any similar requirements established pursuant to state law. Makes exceptions for such an inspection if: (1) the state or subdivision makes a determination that a drug or device presents a threat of serious adverse health consequences or death; (2) the Secretary of Health and Human Services (HHS) orders a recall of a drug, biological product, or device manufactured, processed, packed, or held at the factory, warehouse, or establishment; or (3) the Secretary requests or authorizes the state to conduct or require the inspection.

Science and Technology Regulatory Relief Act of 2012

Rep. Brian Bilbray [R-CA]	Rep. Mary Bono Mack [R-CA]	Rep. Ken Calvert [R-CA]	Rep. Susan Davis [D-CA]
Rep. Duncan Hunter [R-CA]	Rep. Jerry Lewis [R-CA]	Rep. Edward Royce [R-CA]

Date	Chamber	Action
2012-02-16	House	Referred to the House Committee on Energy and Commerce.

Type	Source
Summary	https://www.congress.gov/bill/112th-congress/house-bill/4056/all-info
Text	https://www.congress.gov/112/bills/hr4056/BILLS-112hr4056ih.pdf